Stay updated on Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial page.

Latest updates to the Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial page
- ChecktodayChange DetectedRevision: v3.3.4 replaces v3.3.3; no visible changes to the page content or study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check7 days agoChange Detected- Added related topics: Multiple myeloma and MedlinePlus Genetics to the page's related topics section.SummaryDifference0.1%

- Check15 days agoChange DetectedRemoved 'Multiple myeloma' and 'MedlinePlus Genetics' from the Related Topics section. The change does not affect core study content or enrollment criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check22 days agoChange DetectedLocations section updated to include Canada (Alberta, British Columbia, Ontario) and Rome; removed U.S. state locations (Alabama, Georgia, Massachusetts, New York, South Carolina, Washington). Revision label updated to v3.3.3.SummaryDifference0.8%

- Check29 days agoChange Detected- Removed 'Multiple myeloma' and 'MedlinePlus Genetics' from the Related Topics section.SummaryDifference0.1%

- Check51 days agoChange DetectedAdded related topic tag: Multiple myeloma and a MedlinePlus Genetics link. Revision updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial page.